GAIA BioMedicine is conducting clinical development of cancer immunotherapy using their originally defined natural killer-like cells.
Company name
GAIA BioMedicine, Co., Ltd.
Type of business
Medical(medical devices, drug discovery)
Representatives
Kazuyuki Kuramori
Establishing a company
October 2015
Investment announcement date
July 2025
Capitalist
Yoshiharu Uruno
HP
https://gaia-biomed.com/Phasing
Middle to Growth
